For three decades, Leerink has partnered with visionaries who are shaping the future of healthcare. We provide financial solutions that help innovators develop new therapeutics, technologies, tools, and diagnostics that are transforming healthcare.

Mr. Leerink founded Leerink Partners in 1995 to provide differentiated healthcare knowledge across mergers and acquisitions, equity capital markets, and equity research to help its clients define and achieve their strategic and capital markets objectives.

Investors and corporate clients repeatedly turn to Leerink Partners’ experience and expertise to unlock the growth potential of innovative biopharma companies. Recent transactions $185 Million

Jeffrey A. Leerink is the Chairman and Chief Executive Officer of Leerink Partners, the largest independent investment bank dedicated exclusively to healthcare. Since its founding three decades ago, Leerink Partners has emerged as a leading investment bank known for its expertise in equity research, equity capital markets, and M&A.

With Equity Research provided by Leerink Partners, Investors Benefit from Our Depth of Coverage in Healthcare – spanning key sub-sectors such as; Biopharma, Digital Health, Healthcare Services, Medical Technology, and Tools & Diagnostics.

Boston, MA, June 18, 2023 – The SVB Securities management team bidder group led by CEO Jeff Leerink, and backed by The Baupost Group, today announced they have entered into a definitive agreement with SVB Financial Group (Pink Sheets: SIVBQ) to purchase SVB Securities following a competitive bidding process.

Nov 12, 2024 · Leerink Partners' Articles – sharing our deep expertise and experience in Healthcare to help fuel our customers' next breakthrough innovation.

Nov 1, 2024 · With a notable track record building healthcare investment banking businesses and delivering results for clients, Tom will advance Leerink Partners’ strategic goals across the platform, and will drive the build-out of a world class M&A business.

Drawing on over three decades of experience advising CEOs and boards in the biopharma sector, Tom is focused on building a world class Mergers & Acquisitions business at Leerink Partners. Over the last decade, Tom has been one of the most …

Nov 22, 2024 · Leerink Partners Coverage List Updated on: 11/22/2024 Shares Outstanding Market Cap Company Ticker Rating Analyst Sector Year Closing Price ($) 2023A ($)